5 days Morgan Stanley Trims Immunocore (NASDAQ:IMCR) Target Price to $74.00MarketBeat
Morgan Stanley reduced their target price on Immunocore from $80.00 to $74.00 and set an “overweight” rating for the company in a research note on Friday.
Morgan Stanley (MS) · Nasdaq 100 · Science
X